Spectral AI, Inc. (Nasdaq: MDAI) is a medical-technology company focused on artificial-intelligence-powered wound and burn assessment diagnostics, operating in the healthcare AI sector. The company completed its SPAC business combination in 2023 and has since traded on Nasdaq under the MDAI ticker as a post-merger public company. On June 1, 2026, Spectral AI filed an 8-K current report with the SEC under accession number 0001213900-26-063486, disclosing a material event as required under Exchange Act reporting obligations. The company's core platform uses AI to predict wound healing outcomes, targeting burn centers and trauma care facilities. For the full filing detail, sponsor history, and real-time MDAI data, sign up for SpacDesk at spacdesk.com.